ResMed Inc. (RMD) reported $5.73B of revenue for the twelve months ended Sep 30, 2026. That is up 9.0% from the year before. Revenue for fiscal 2026 was $5.65B.

Yes. ResMed Inc. earned $1.59B in net income for the twelve months ended Sep 30, 2026, a net margin of 27.8%.

How much cash and debt does RMD have?

ResMed Inc. reported $1.01B in cash and cash equivalents and $409.60M of debt on its most recent balance sheet in SEC filings.

How fast is RMD revenue growing?

ResMed Inc.'s revenue changed +9.9% in fiscal 2026, to $5.65B. Its compound annual growth rate was +12.1% over 5 years and +11.9% over 10 years.

What is RMD gross margin?

ResMed Inc.'s gross profit was $3.50B on $5.73B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 61.1%.

What is RMD free cash flow?

ResMed Inc. generated $1.61B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.77B less capital expenditures.

What is RMD earnings per share?

Diluted earnings per share were $10.98 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did RMD last report financial results?

The latest statements here come from ResMed Inc.'s 10-Q filed on Oct 30, 2026, covering the period ended Sep 30, 2026.

Where does this RMD financial data come from?

Quantisnow builds these statements from the structured XBRL data ResMed Inc. files with the SEC. It is provided for information only and is not investment advice.

Financials · RMD

ResMed Inc. (RMD) financials

For the twelve months ended Sep 30, 2026, ResMed Inc. reported $5.73B of revenue and $1.59B of net income.

Revenue, TTM: $5.73B
Revenue growth, YoY: +9.0%
Net income, TTM: $1.59B
Net income growth, YoY: +10.8%
Net margin: 27.8%
Free cash flow, TTM: $1.61B
EPS, diluted, TTM: $10.98
EPS growth, YoY: +12.4%
Cash: $1.01B
Total debt: $409.60M
P/E: 20.77
P/S: 5.77
Market cap: $33.10B

Annual revenue$5.65B

FY2017FY2026

Annual net income$1.52B

FY2017FY2026

Annual free cash flow$1.65B

FY2017FY2026

RMD revenue and earnings growth

RMD revenueQ1 2027$1.41B

Quarter YoY: +5.9%
QoQ: -3.3%
FY YoY: +9.9%
5Y CAGR: +12.1%
10Y CAGR: +11.9%

RMD revenue was $1.41B in fiscal Q1 2027 (ended Sep 30, 2026), up 5.9% from a year earlier and down 3.3% from the prior quarter. For the full fiscal 2026 it was $5.65B, up 9.9% from fiscal 2025. Compound annual growth was +12.1% over 5 years and +11.9% over 10 years. It rose in each of the last 10 fiscal years. Fiscal 2026 is the highest of the 15 fiscal years on file.

RMD net incomeQ1 2027$418.41M

Quarter YoY: +20.0%
QoQ: +9.1%
FY YoY: +8.8%
5Y CAGR: +26.3%
10Y CAGR: +15.8%

RMD net income was $418.41M in fiscal Q1 2027 (ended Sep 30, 2026), up 20.0% from a year earlier and up 9.1% from the prior quarter. For the full fiscal 2026 it was $1.52B, up 8.8% from fiscal 2025. Compound annual growth was +26.3% over 5 years and +15.8% over 10 years. It rose in 7 of the last 10 fiscal years. Fiscal 2026 is the highest of the 15 fiscal years on file.

RMD EPSQ1 2027$2.92

Quarter YoY: +23.2%
QoQ: +10.6%
FY YoY: +9.7%
5Y CAGR: +26.3%
10Y CAGR: +15.4%

RMD diluted EPS was $2.92 in fiscal Q1 2027 (ended Sep 30, 2026), up 23.2% from a year earlier and up 10.6% from the prior quarter. For the full fiscal 2026 it was $10.43, up 9.7% from fiscal 2025. Compound annual growth was +26.3% over 5 years and +15.4% over 10 years.

RMD free cash flowQ1 2027$373.68M

Quarter YoY: -9.8%
QoQ: -7.4%
FY YoY: -0.7%
5Y CAGR: +21.1%
10Y CAGR: +12.9%

RMD free cash flow was $373.68M in fiscal Q1 2027 (ended Sep 30, 2026), down 9.8% from a year earlier and down 7.4% from the prior quarter. For the full fiscal 2026 it was $1.65B, down 0.7% from fiscal 2025. Compound annual growth was +21.1% over 5 years and +12.9% over 10 years. It rose in 5 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2026 Jun 30, 2026	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017
Revenue	$5.65B	$5.15B	$4.69B	$4.22B	$3.58B	$3.20B	$2.96B	$2.61B	$2.34B	$2.07B
Cost of revenue	$2.20B	$2.09B	$2.03B	$1.87B	$1.55B	$1.36B	$1.24B	$1.11B	$1.01B	$864.99M
Gross profit	$3.45B	$3.05B	$2.66B	$2.36B	$2.02B	$1.84B	$1.72B	$1.49B	$1.33B	$1.20B
Research and development	$378.29M	$331.28M	$307.52M	$287.64M	$253.57M	$225.28M	$201.95M	$180.65M	$155.15M	$144.47M
Selling, general and admin	$1.12B	$993.05M	$917.14M	$874.00M	$737.51M	$670.39M	$676.69M	$645.01M	$600.37M	$553.97M
Operating income	$1.89B	$1.69B	$1.32B	$1.13B	$1.00B	$903.68M	$809.66M	$579.26M	$541.83M	$425.80M
Interest expense	-	-	-	-	-	$23.99M	$40.38M	$36.16M	$28.36M	$28.24M
Pre-tax income	$1.92B	$1.68B	$1.26B	$1.10B	$960.48M	$883.66M	$733.09M	$518.85M	$521.31M	$418.74M
Income tax	$396.12M	$276.84M	$243.85M	$204.11M	$181.05M	$409.16M	$111.41M	$114.25M	$205.72M	$76.46M
Net income	$1.52B	$1.40B	$1.02B	$897.56M	$779.44M	$474.50M	$621.67M	$404.59M	$315.59M	$342.28M
EPS, basic	$10.47	$9.55	$6.94	$6.12	$5.34	$3.27	$4.31	$2.83	$2.21	$2.42
EPS, diluted	$10.43	$9.51	$6.92	$6.09	$5.30	$3.24	$4.27	$2.80	$2.19	$2.40
Diluted shares	146.1M	147.3M	147.6M	147.5M	147.0M	146.5M	145.7M	144.5M	144.0M	142.5M

Balance sheet

Balance sheet
Line item	FY2026 Jun 30, 2026	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017
Cash and equivalents	$1.47B	$1.21B	$238.36M	$227.89M	$273.71M	$295.28M	$463.16M	$147.13M	$188.70M	$821.93M
Receivables	$1.04B	$939.49M	$837.27M	$704.91M	$575.95M	$614.29M	$474.64M	$528.48M	$483.68M	$450.53M
Inventory	$945.80M	$927.71M	$822.25M	$998.01M	$743.91M	$457.03M	$416.92M	$349.64M	$268.70M	$268.32M
Current assets	$4.32B	$3.51B	$2.36B	$2.37B	$1.93B	$1.57B	$1.52B	$1.15B	$1.07B	$1.64B
Goodwill	$2.91B	$3.05B	$2.84B	$2.77B	$1.94B	$1.93B	$1.89B	$1.86B	$1.07B	$1.06B
Total assets	$8.97B	$8.17B	$6.87B	$6.75B	$5.10B	$4.73B	$4.59B	$4.11B	$3.06B	$3.47B
Current liabilities	$1.40B	$1.02B	$910.65M	$758.53M	$689.30M	$911.77M	$602.76M	$555.99M	$511.25M	$360.13M
Short-term debt	$259.95M	$9.90M	$9.90M	$9.90M	$9.92M	$12.00M	$11.99M	$11.99M	$11.47M	-
Long-term debt	-	-	-	-	-	-	-	-	-	$1.08B
Total debt	$659.37M	$668.29M	$707.21M	$1.44B	$775.24M	$655.35M	$1.18B	$1.27B	$281.45M	$1.08B
Total liabilities	$2.38B	$2.21B	$2.01B	$2.62B	$1.74B	$1.84B	$2.09B	$2.04B	$1.00B	$1.51B
Shareholders' equity	$6.59B	$5.97B	$4.86B	$4.13B	$3.36B	$2.89B	$2.50B	$2.07B	$2.06B	$1.96B

Cash flow

Cash flow
Line item	FY2026 Jun 30, 2026	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017
Operating cash flow	$1.81B	$1.75B	$1.40B	$693.30M	$351.15M	$736.72M	$802.25M	$459.05M	$505.03M	$414.05M
Capital expenditures	$156.28M	$89.86M	$99.46M	$119.67M	$134.84M	$102.71M	$95.33M	$68.71M	$62.58M	$62.22M
Free cash flow	$1.65B	$1.66B	$1.30B	$573.63M	$216.31M	$634.01M	$706.92M	$390.34M	$442.44M	$351.83M
Investing cash flow	-$545.20M	-$200.04M	-$269.78M	-$1.16B	-$229.92M	-$158.46M	-$179.86M	-$1.08B	-$101.82M	-$81.89M
Financing cash flow	-$1.01B	-$606.25M	-$1.12B	$422.87M	-$128.36M	-$764.63M	-$317.29M	$580.64M	-$1.03B	-$262.87M
Dividends paid	$349.66M	$310.88M	$282.32M	$258.28M	$245.34M	$226.71M	$225.09M	$211.71M	$199.50M	$186.35M
Share repurchases	$700.04M	$300.02M	$150.01M	$0	$0	-	-	$22.84M	$53.80M	-
Stock-based compensation	$104.35M	$91.66M	$80.18M	$71.14M	$65.26M	$63.93M	$57.56M	$52.07M	$48.41M	$45.92M
Depreciation and amortization	$201.34M	$198.47M	$176.87M	$165.16M	$159.61M	$156.76M	$154.85M	$150.79M	$119.96M	$112.16M

Key ratios

Key ratios
Line item	FY2026 Jun 30, 2026	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017
Revenue growth, YoY	9.9%	9.8%	10.9%	18.0%	11.9%	8.1%	13.4%	11.4%	13.2%	12.4%
Net income growth, YoY	8.8%	37.2%	13.7%	15.2%	64.3%	-23.7%	53.7%	28.2%	-7.8%	-2.9%
EPS growth, YoY	9.7%	37.4%	13.6%	14.9%	63.6%	-24.1%	52.5%	27.9%	-8.8%	-3.6%
Gross margin	61.1%	59.4%	56.7%	55.8%	56.6%	57.5%	58.1%	57.3%	57.0%	58.1%
Operating margin	33.4%	32.7%	28.2%	26.8%	28.0%	28.3%	27.4%	22.2%	23.2%	20.6%
Net margin	26.9%	27.2%	21.8%	21.3%	21.8%	14.8%	21.0%	15.5%	13.5%	16.6%
Free cash flow margin	29.2%	32.3%	27.8%	13.6%	6.0%	19.8%	23.9%	15.0%	18.9%	17.0%
Return on equity	23.1%	23.5%	21.0%	21.7%	23.2%	16.4%	24.9%	19.5%	15.3%	17.5%
Return on assets	17.0%	17.1%	14.9%	13.3%	15.3%	10.0%	13.6%	9.8%	10.3%	9.9%
Current ratio	3.10	3.44	2.59	3.12	2.80	1.73	2.53	2.06	2.08	4.57
Debt to equity	0.10	0.11	0.15	0.35	0.23	0.23	0.47	0.61	0.14	0.55

Income statement

Income statement
Line item	Q1 2027 Sep 30, 2026	Q4 2026* Jun 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023
Revenue	$1.41B	$1.46B	$1.43B	$1.42B	$1.34B	$1.35B	$1.29B	$1.28B	$1.22B	$1.22B	$1.20B	$1.16B
Cost of revenue	$544.25M	$602.43M	$540.43M	$544.08M	$517.92M	$527.92M	$525.33M	$530.81M	$507.29M	$507.67M	$504.20M	$515.87M
Gross profit	$870.57M	$861.22M	$890.98M	$878.72M	$817.66M	$820.07M	$766.41M	$751.27M	$717.22M	$715.53M	$692.78M	$646.93M
Research and development	$102.86M	$105.72M	$94.27M	$90.97M	$89.48M	$86.44M	$83.94M	$81.37M	$79.52M	$80.86M	$77.07M	$73.88M
Selling, general and admin	$314.72M	$296.28M	$285.65M	$278.40M	$281.65M	$267.16M	$245.30M	$241.61M	$238.98M	$242.19M	$229.92M	$222.16M
Operating income	$452.98M	$448.71M	$499.81M	$491.66M	$446.54M	$454.54M	$426.27M	$417.24M	$387.31M	$381.22M	$374.58M	$275.09M
Interest expense	$4.81M	-	-	-	$7.12M	-	-	-	-	-	-	-
Pre-tax income	$539.15M	$474.16M	$502.31M	$496.15M	$446.79M	$458.05M	$417.69M	$418.32M	$383.50M	$357.73M	$375.42M	$259.45M
Income tax	$120.74M	$90.73M	$103.58M	$103.56M	$98.26M	$78.35M	$52.65M	$73.70M	$72.14M	$65.50M	$74.93M	$50.65M
Net income	$418.41M	$383.43M	$398.73M	$392.59M	$348.54M	$379.70M	$365.04M	$344.62M	$311.36M	$292.24M	$300.49M	$208.80M
EPS, basic	$2.93	$2.66	$2.74	$2.69	$2.38	$2.59	$2.49	$2.35	$2.12	$1.99	$2.04	$1.42
EPS, diluted	$2.92	$2.64	$2.74	$2.68	$2.37	$2.58	$2.48	$2.34	$2.11	$1.97	$2.04	$1.42
Diluted shares	143.4M	-	145.7M	146.4M	146.9M	-	147.2M	147.5M	147.6M	-	147.4M	147.5M

Balance sheet

Balance sheet
Line item	Q1 2027 Sep 30, 2026	Q4 2026* Jun 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023
Cash and equivalents	$1.01B	$1.47B	$1.66B	$1.42B	$1.38B	$1.21B	$932.71M	$521.94M	$426.36M	$238.36M	$237.91M	$210.25M
Receivables	$972.50M	$1.04B	$998.84M	$985.63M	$907.27M	$939.49M	$907.83M	$859.94M	$811.20M	$837.27M	$779.26M	$729.74M
Inventory	$1.02B	$945.80M	$911.88M	$922.04M	$945.81M	$927.71M	$862.64M	$882.10M	$917.98M	$822.25M	$829.46M	$933.21M
Current assets	$3.51B	$4.32B	$4.06B	$3.82B	$3.63B	$3.51B	$3.21B	$2.84B	$2.64B	$2.36B	$2.35B	$2.38B
Goodwill	$2.91B	$2.91B	$3.04B	$3.04B	$3.04B	$3.05B	$2.85B	$2.81B	$2.89B	$2.84B	$2.84B	$2.86B
Total assets	$8.21B	$8.97B	$8.78B	$8.50B	$8.31B	$8.17B	$7.57B	$7.14B	$7.22B	$6.87B	$6.81B	$6.91B
Current liabilities	$1.32B	$1.40B	$1.35B	$1.25B	$1.26B	$1.02B	$940.52M	$851.96M	$904.08M	$910.65M	$773.03M	$764.07M
Short-term debt	$159.97M	$259.95M	$259.93M	$259.91M	$259.90M	$9.90M	$9.91M	$9.91M	$9.90M	$9.90M	$9.90M	$9.90M
Total debt	$409.60M	$659.37M	$664.10M	$663.83M	$668.56M	$668.29M	$673.03M	$672.76M	$677.47M	$707.21M	$1.01B	$1.23B
Total liabilities	$2.26B	$2.38B	$2.29B	$2.18B	$2.19B	$2.21B	$2.02B	$1.89B	$2.03B	$2.01B	$2.18B	$2.42B
Shareholders' equity	$5.95B	$6.59B	$6.49B	$6.32B	$6.12B	$5.97B	$5.55B	$5.25B	$5.20B	$4.86B	$4.63B	$4.48B

Cash flow

Cash flow
Line item	Q1 2027 Sep 30, 2026	Q4 2026* Jun 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023
Operating cash flow	$422.42M	$454.63M	$554.13M	$339.75M	$457.32M	$538.77M	$578.66M	$308.62M	$325.54M	$440.11M	$402.03M	$272.83M
Capital expenditures	$48.74M	$51.13M	$33.65M	$28.54M	$42.97M	$30.59M	$20.80M	$20.64M	$17.84M	$24.88M	$21.19M	$23.35M
Free cash flow	$373.68M	$403.50M	$520.48M	$311.21M	$414.36M	$508.18M	$557.87M	$287.98M	$307.70M	$415.23M	$380.84M	$249.48M
Investing cash flow	$392.06M	-$383.65M	-$58.03M	-$50.94M	-$52.58M	-$133.71M	-$31.79M	-$36.69M	$2.15M	-$46.51M	-$33.15M	-$41.14M
Financing cash flow	-$1.28B	-$263.16M	-$255.24M	-$258.35M	-$230.27M	-$163.89M	-$144.07M	-$147.54M	-$150.76M	-$393.28M	-$335.91M	-$238.96M
Dividends paid	$94.95M	$87.09M	$87.24M	$87.58M	$87.75M	$77.59M	$77.70M	$77.69M	$77.89M	$70.55M	$70.49M	$70.68M
Share repurchases	$936.38M	$200.00M	$175.01M	$175.01M	$150.01M	$100.01M	$75.03M	$74.99M	$50.01M	$50.00M	$50.00M	$50.01M
Stock-based compensation	$29.48M	$27.46M	$26.79M	$28.94M	$21.16M	$24.75M	$24.12M	$22.63M	$20.16M	$21.39M	$20.44M	$19.84M
Depreciation and amortization	$41.74M	$44.78M	$58.98M	$49.88M	$47.70M	$63.63M	$43.67M	$46.44M	$44.73M	$43.68M	$43.47M	$44.78M

Key ratios

Key ratios
Line item	Q1 2027 Sep 30, 2026	Q4 2026* Jun 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023
Revenue growth, YoY	5.9%	8.6%	10.8%	11.0%	9.1%	10.2%	7.9%	10.3%	11.1%	9.0%	7.2%	12.5%
Net income growth, YoY	20.0%	1.0%	9.2%	13.9%	11.9%	29.9%	21.5%	65.0%	41.9%	27.2%	29.2%	-7.2%
EPS growth, YoY	23.2%	2.3%	10.5%	14.5%	12.3%	31.0%	21.6%	64.8%	41.6%	27.1%	29.1%	-7.2%
Gross margin	61.5%	58.8%	62.2%	61.8%	61.2%	60.8%	59.3%	58.6%	58.6%	58.5%	57.9%	55.6%
Operating margin	32.0%	30.7%	34.9%	34.6%	33.4%	33.7%	33.0%	32.5%	31.6%	31.2%	31.3%	23.7%
Net margin	29.6%	26.2%	27.9%	27.6%	26.1%	28.2%	28.3%	26.9%	25.4%	23.9%	25.1%	18.0%
Free cash flow margin	26.4%	27.6%	36.4%	21.9%	31.0%	37.7%	43.2%	22.5%	25.1%	33.9%	31.8%	21.5%
Current ratio	2.65	3.10	3.01	3.06	2.89	3.44	3.41	3.33	2.92	2.59	3.04	3.11
Debt to equity	0.07	0.10	0.10	0.11	0.11	0.11	0.12	0.13	0.13	0.15	0.22	0.27

Source: XBRL data ResMed Inc. files with the SEC, latest filing dated Oct 30, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

RMD peers

Company	Revenue	Growth	Net income	Net margin	Market cap
RMD	$5.73B	+9.0%	$1.59B	27.8%	$33.10B
SYKStryker Corporation	$26.30B	+7.9%	$3.62B	13.8%	$124.05B
MMM3M Company	$25.25B	+1.7%	$3.54B	14.0%	$95.67B
BSXBoston Scientific Corporation	$21.07B	+8.9%	$3.50B	16.6%	$61.96B
BDXBecton Dickinson and Company	$23.25B	+17.4%	$941.00M	4.0%	$57.71B
MDLNMedline Inc.	$30.68B	-	$683.00M	2.2%	$52.13B
DXCMDexCom Inc.	$5.10B	+13.0%	$991.00M	19.4%	$29.62B
WSTWest Pharmaceutical Services Inc.	$3.40B	+12.6%	$638.90M	18.8%	$27.85B
SOLVSolventum Corporation	$8.16B	-2.8%	$156.00M	1.9%	$15.38B

RMD FAQ

9 questions

What is RMD revenue?
ResMed Inc. (RMD) reported $5.73B of revenue for the twelve months ended Sep 30, 2026. That is up 9.0% from the year before. Revenue for fiscal 2026 was $5.65B.
Is RMD profitable?
Yes. ResMed Inc. earned $1.59B in net income for the twelve months ended Sep 30, 2026, a net margin of 27.8%.
How much cash and debt does RMD have?
ResMed Inc. reported $1.01B in cash and cash equivalents and $409.60M of debt on its most recent balance sheet in SEC filings.
How fast is RMD revenue growing?
ResMed Inc.'s revenue changed +9.9% in fiscal 2026, to $5.65B. Its compound annual growth rate was +12.1% over 5 years and +11.9% over 10 years.
What is RMD gross margin?
ResMed Inc.'s gross profit was $3.50B on $5.73B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 61.1%.
What is RMD free cash flow?
ResMed Inc. generated $1.61B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.77B less capital expenditures.
What is RMD earnings per share?
Diluted earnings per share were $10.98 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did RMD last report financial results?
The latest statements here come from ResMed Inc.'s 10-Q filed on Oct 30, 2026, covering the period ended Sep 30, 2026.
Where does this RMD financial data come from?
Quantisnow builds these statements from the structured XBRL data ResMed Inc. files with the SEC. It is provided for information only and is not investment advice.